A Study of Electrocardiogram and Focused Cardiac Ultrasound for Enhanced Cardiac Disease Screening
Integrating Electrocardiogram and Focused Cardiac Ultrasound for Enhanced Cardiac Disease Screening; Structural Cardiac Assessment With Networked AI-ECG & FOCUS (SCAN) Study
Mayo Clinic
10,500 participants
Apr 14, 2025
OBSERVATIONAL
Conditions
Summary
The purpose of this study is to evaluate and compare the effectiveness of active screening for SHD in asymptomatic outpatients referred for an ECG, using a combination of AI-ECG and FOCUS. Invites will be sent and participants enrolled electronically.
Eligibility
Inclusion Criteria2
- Adult patients (>18 years of age)
- Echocardiogram is not clinically indicated
Exclusion Criteria11
- Prior history of congenital or acquired SHD, as defined by the following
- Aortic Stenosis:
- Heart Failure
- Left Ventricular Dysfunction
- Cardiac Amyloidosis
- Hypertrophic Cardiomyopathy (HCM)
- Rheumatic Heart Disease
- Congenital Heart Disease
- Recent (within last 12 months) echocardiogram
- Scheduled clinically indicated future echocardiogram
- Inability to provide informed consent to participate in the study
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Participants will undergo electrocardiogram analysis using AI-ECG during the baseline visit
Participants will undergo a focused cardiac ultrasound if the AI-ECG reflects a positive value
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06891222